Clinical Trial Update: Evaluation of a New Laser Refractive Vision Correction Using the TENEO™ 317 Model 2 [NA]

View source ↗

Summary

A clinical trial is evaluating a new laser refractive vision correction device, the TENEO 317 Model 2, from Bausch & Lomb GmbH, for hyperopia and myopia, and th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperopia
• Myopia

Drugs mentioned

• TENEO 317 Model 2

Snippet

Sponsor: Bausch & Lomb GmbH | Conditions: Hyperopia and Myopia | NA | Status: RECRUITING